Clinical, neuropathological, and genetic characterization of STUB1 variants in cerebellar ataxias: a frequent cause of predominant cognitive impairment (vol 22, pg 1851, 2020)
Genetics in Medicine. 2021-10-01; 23(10): 2021
DOI: 10.1038/S41436-020-01064-Y
Read on PubMed
1. Genet Med. 2021 Oct;23(10):2021. doi: 10.1038/s41436-020-01064-y.
Correction: Clinical, neuropathological, and genetic characterization of STUB1
variants in cerebellar ataxias: a frequent cause of predominant cognitive
impairment.
Roux T(#)(1), Barbier M(#)(1), Papin M(#)(1)(2), Davoine CS(1)(2), Sayah S(1),
Coarelli G(1), Charles P(3), Marelli C(4), Parodi L(1), Tranchant C(5), Goizet
C(6), Klebe S(7), Lohmann E(8), Van Maldergem L(9), van Broeckhoven C(10),
Coutelier M(1)(2), Tesson C(1), Stevanin G(1)(2), Duyckaerts C(1), Brice A(1),
Durr A(11); SPATAX network.
Collaborators: Durr A, Stevanin G, Brice A, Darios F, Forlani S, Site PS, Banneau
G, Cazeneuve C, Charles P, Duyckaerts C, Fontaine B, Azulay JP, Boesfplug-Tanguy
O, Goizet C, Hannequin D, Hazan J, Burgo A, Verny C, Koenig M, Labauge P, Marelli
C, N’guyen K, Rodriguez D, Belarbi S, Hamri A, Tazir M, Boesch S, Pandolfo M,
Laura J, Guergueltcheva V, Tournev I, Pedraza Linarès OL, Nielsen JE, Svenstrup
K, Zaki M, Bauer P, Schöls L, Schüle R, Lossos A, Bassi MT, Basso M, Bertini E,
Brusco A, Casali C, Casari G, Criscuolo C, Filla A, Orsi L, Santorelli FM,
Valente EM, Vavla M, Vazza G, Megarbane A, Benomar A, Kremer B, Van Roon-Mom W,
Roxburgh R, Erichsen AK, Tallaksen C, Alonso I, Coutinho P, Loureiro JL,
Sequeiros J, Salih M, Kostic VS, Rouco Axpe I, Elsayed L, Paucar MA, Roumani S,
Bing-Wen S, Reid E, Suran N, Warner T, Wood N.
Author information:
(1)Sorbonne Université, Institut du Cerveau-Paris Brain Institute (ICM), AP-HP,
INSERM, CNRS, University Hospital Pitié-Salpêtrière, Paris, France.
(2)EPHE, PSL Research University, Neurogenetics Group, Paris, France.
(3)Genetic Department, University Hospital Pitié-Salpêtrière, AP-HP, Paris,
France.
(4)Expert center for Neurogenetic Diseases, Department of Neurology, CHU Gui de
Chauliac, MMDN, Univ Montpellier, INSERM, EPHE, Montpellier, France.
(5)Neurological Department University Hospital Strasbourg, Strasbourg, France.
(6)University Bordeaux, Laboratoire MRGM, INSERM U1211, Centre de Référence
Neurogénétique, Service de Génétique Médicale, CHU Bordeaux, Bordeaux, France.
(7)University Hospital Essen, Department of Neurology, Essen, Germany.
(8)Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain
Research, University of Tübingen, Tübingen, Germany.
(9)Université de Franche-Comté, Centre de Génétique Humaine, Centre Hospitalier
Régional Universitaire, Besançon, France.
(10)Neurodegenerative Brain Diseases Group, VIB Center for Molecular Neurology,
Laboratory of Neurogenetics, Institute Born-Bunge and Department of Biomedical
Sciences, University of Antwerp, Antwerp, Belgium.
(11)Sorbonne Université, Institut du Cerveau-Paris Brain Institute (ICM), AP-HP,
INSERM, CNRS, University Hospital Pitié-Salpêtrière, Paris, France.
.
(#)Contributed equally
Erratum for
Genet Med. 2020 Nov;22(11):1851-1862.
DOI: 10.1038/s41436-020-01064-y
PMID: 33353973